Aimovig and Folliculitis - a phase IV clinical study of FDA data
Summary:
Folliculitis is reported as a side effect among people who take Aimovig (erenumab-aooe), especially for people who are female, 40-49 old, have been taking the drug for 2 - 5 years also take Cosentyx, and have Rheumatoid arthritis.
The phase IV clinical study analyzes which people have Folliculitis when taking Aimovig. It is created by eHealthMe based on reports of 49,844 people who have side effects when taking Aimovig from the FDA, and is updated regularly.
What is Aimovig?
Aimovig has active ingredients of erenumab-aooe. eHealthMe is studying from 49,930 Aimovig users. Check the latest studies of Aimovig.
What is Folliculitis?
Folliculitis (infection of hair root) is found to be associated with 688 drugs and 1,071 conditions by eHealthMe. Check the latest studies of Folliculitis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
49,844 people reported to have side effects when taking Aimovig.
Among them, 168 people (0.34%) have Folliculitis.

Among these 168 people:
How long have people been on Aimovig when they have Folliculitis? *
What is the gender of people who have Folliculitis when taking Aimovig? *
What is the age of people who have Folliculitis when taking Aimovig? *
What are other drugs people take besides Aimovig? *
What are other side effects people have besides Folliculitis? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Aimovig and have Folliculitis?
- Check whether Folliculitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Aimovig:
- Aimovig (49,930 reports)
Folliculitis treatments and more:
- Folliculitis (10,844 reports)
How severe was Folliculitis and when was it recovered:
Expand to all the drugs that have ingredients of erenumab-aooe:
- Folliculitis and drugs with ingredients of erenumab-aooe (175 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Aimovig:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Folliculitis:
- Folliculitis (688 drugs)
Browse all the conditions that are associated with Folliculitis:
- Folliculitis (1,071 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on erenumab-aooe (the active ingredients of Aimovig) and Aimovig (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Sulfasalazine and Plaquenil drug interactions for men aged 60+ - 4 seconds ago
- Dexmedetomidine and Thrombocytopenia for Men aged 60+ - 5 seconds ago
- Dexmedetomidine and Low Platelet Count for Men aged 60+ - 6 seconds ago
- Dexmedetomidine and Platelet Count Decreased for Men aged 60+ - 6 seconds ago
- Dexmedetomidine and Thin Blood for Men aged 60+ - 6 seconds ago
- Dexmedetomidine and Low Blood Platelet Count for Men aged 60+ - 6 seconds ago
- Could Metoprolol Tartrate cause Facial Paralysis? - 10 seconds ago
- Could Tamsulosin cause Hemiplegia? - 16 seconds ago
- Drug interactions of Doxepin Hydrochloride and Choline - 38 seconds ago
- Could Viagra cause Chest Pain? - 45 seconds ago